| The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014 R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ... Annals of Oncology 26 (2), 259-271, 2015 | 2744 | 2015 |
| Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199 S Adams, RJ Gray, S Demaria, L Goldstein, EA Perez, LN Shulman, ... Journal of Clinical Oncology 32 (27), 2959-2966, 2014 | 1375 | 2014 |
| Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial EB Golden, A Chhabra, A Chachoua, S Adams, M Donach, ... The Lancet Oncology 16 (7), 795-803, 2015 | 646 | 2015 |
| Manipulating dendritic cell biology for the active immunotherapy of cancer DW O'Neill, S Adams, N Bhardwaj Blood 104 (8), 2235-2246, 2004 | 472 | 2004 |
| Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival D Bogunovic, DW O'Neill, I Belitskaya-Levy, V Vacic, YL Yu, S Adams, ... Proceedings of the National Academy of Sciences 106 (48), 20429-20434, 2009 | 414 | 2009 |
| Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming D Valmori, NE Souleimanian, V Tosello, N Bhardwaj, S Adams, D O'Neill, ... Proceedings of the National Academy of Sciences 104 (21), 8947-8952, 2007 | 346 | 2007 |
| Toll-like receptor agonists in cancer therapy S Adams Immunotherapy 1 (6), 949-964, 2009 | 329 | 2009 |
| Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant S Adams, DW O'Neill, D Nonaka, E Hardin, L Chiriboga, K Siu, CM Cruz, ... The Journal of Immunology 181 (1), 776-784, 2008 | 300 | 2008 |
| Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer S Adams, L Kozhaya, F Martiniuk, TC Meng, L Chiriboga, L Liebes, ... Clinical Cancer Research 18 (24), 6748-6757, 2012 | 245 | 2012 |
| Erratum: Recent Advances in Dendritic Cell Biology S Adams, DW O’Neill, N Bhardwaj Journal of clinical immunology 25 (3), 175-188, 2005 | 231 | 2005 |
| Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer MZ Dewan, C Vanpouille-Box, N Kawashima, S DiNapoli, JS Babb, ... Clinical Cancer Research 18 (24), 6668-6678, 2012 | 173 | 2012 |
| Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors EF Velazquez, AA Jungbluth, M Yancovitz, S Gnjatic, S Adams, D O'Neill, ... Cancer Immunity Archive 7 (1), 11, 2007 | 146 | 2007 |
| Clinical cancer advances 2011: annual report on progress against cancer from the American Society of Clinical Oncology NJ Vogelzang, SI Benowitz, S Adams, C Aghajanian, SM Chang, ... Journal of Clinical Oncology 30 (1), 88-109, 2012 | 127 | 2012 |
| Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer X Wu, Y Li, J Wang, X Wen, MT Marcus, G Daniels, DY Zhang, F Ye, ... PloS one 8 (10), e77060, 2013 | 107 | 2013 |
| Clinical cancer advances 2013: annual report on progress against cancer from the American Society of Clinical Oncology JD Patel, L Krilov, S Adams, C Aghajanian, E Basch, MS Brose, ... Journal of Clinical Oncology 32 (2), 129-160, 2014 | 105 | 2014 |
| CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases J Yuan, B Ginsberg, D Page, Y Li, T Rasalan, HF Gallardo, Y Xu, S Adams, ... Cancer Immunology, Immunotherapy 60 (8), 1137-1146, 2011 | 104 | 2011 |
| Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High Risk Melanoma RL Sabado, A Pavlick, S Gnjatic, CM Cruz, I Vengco, F Hasan, ... Cancer immunology research, canimm. 0202.2014, 2015 | 103 | 2015 |
| Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival S Adams, AB Chakravarthy, M Donach, D Spicer, S Lymberis, B Singh, ... Breast cancer research and treatment 124 (3), 723-732, 2010 | 95 | 2010 |
| Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer JC Singh, Y Novik, S Stein, M Volm, M Meyers, J Smith, C Omene, ... Breast Cancer Res 16 (2), R32, 2014 | 93 | 2014 |
| Contacting sample containing sperm with solution comprising hexuronic acid monomer or with solution comprising polymer comprising hexuronic acid and arabinose or galactose to … JE Ellington, SA Oliver US Patent 6,140,121, 2000 | 88* | 2000 |
